A detailed history of Yorktown Management & Research CO Inc transactions in Globus Medical Inc stock. As of the latest transaction made, Yorktown Management & Research CO Inc holds 6,400 shares of GMED stock, worth $450,496. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,400
Previous 9,300 31.18%
Holding current value
$450,496
Previous $498,000 12.05%
% of portfolio
0.49%
Previous 0.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$49.79 - $68.85 $144,391 - $199,664
-2,900 Reduced 31.18%
6,400 $438,000
Q1 2024

Apr 26, 2024

BUY
$51.15 - $56.52 $148,335 - $163,908
2,900 Added 45.31%
9,300 $498,000
Q1 2020

Apr 29, 2020

BUY
$35.06 - $59.45 $70,120 - $118,900
2,000 Added 45.45%
6,400 $272,000
Q3 2019

Nov 01, 2019

BUY
$40.41 - $52.32 $177,803 - $230,208
4,400 New
4,400 $225,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.42B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Yorktown Management & Research CO Inc Portfolio

Follow Yorktown Management & Research CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.